Yüklüyor......
Targeting ATR and Chk1 kinases for cancer treatment: A new model for new (and old) drugs
Trying to kill cancer cells by generating DNA damage is by no means a new idea. Radiotherapy and genotoxic drugs are routinely used in cancer therapy. More recent developments also explored the potential of targeting the DNA damage response (DDR) in order to increase the toxicity of radio‐ and chemo...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3590794/ https://ncbi.nlm.nih.gov/pubmed/21820372 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2011.07.002 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|